ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,416.45
0.00%
Dow Jones
39,872.99
0.17%
Gold vs US Dollar
2,417.655
-0.16%
Brent Oil
81.835
-0.74%
Bitcoin
69,762.37
-0.53%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Palisade Bio Inc (PALI)

  7. Palisade Bio Inc (PALI) News

Palisade Bio (PALI)

Palisade Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PALI
DateTimeSourceHeadlineSymbolCompany
21/05/202413:30GlobeNewswire Inc.Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Local Bioactivation and Dose Dependent Efficacy Response in Preclinical Mouse ModelsNASDAQ:PALIPalisade Bio Inc
20/05/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PALIPalisade Bio Inc
17/05/202421:51Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PALIPalisade Bio Inc
16/05/202421:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PALIPalisade Bio Inc
14/05/202413:05GlobeNewswire Inc.Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:PALIPalisade Bio Inc
13/05/202421:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PALIPalisade Bio Inc
10/05/202421:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PALIPalisade Bio Inc
10/05/202421:37Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PALIPalisade Bio Inc
10/05/202421:37Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PALIPalisade Bio Inc
08/05/202423:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PALIPalisade Bio Inc
08/05/202423:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PALIPalisade Bio Inc
08/05/202422:06Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PALIPalisade Bio Inc
07/05/202413:30GlobeNewswire Inc.Palisade Bio Appoints Margery Fischbein to its Board of DirectorsNASDAQ:PALIPalisade Bio Inc
07/05/202412:30GlobeNewswire Inc.Palisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq RulesNASDAQ:PALIPalisade Bio Inc
02/05/202413:30GlobeNewswire Inc.Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq RulesNASDAQ:PALIPalisade Bio Inc
01/05/202413:30GlobeNewswire Inc.Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)NASDAQ:PALIPalisade Bio Inc
23/04/202413:30GlobeNewswire Inc.Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine ApproachNASDAQ:PALIPalisade Bio Inc
16/04/202413:30GlobeNewswire Inc.Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients’ StoolNASDAQ:PALIPalisade Bio Inc
11/04/202414:15GlobeNewswire Inc.Palisade Bio to Participate in the Virtual Investor Lunch Break EventNASDAQ:PALIPalisade Bio Inc
10/04/202413:15GlobeNewswire Inc.Palisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn’s & Colitis™NASDAQ:PALIPalisade Bio Inc
03/04/202422:30GlobeNewswire Inc.Palisade Bio Announces 1-for-15 Reverse Stock SplitNASDAQ:PALIPalisade Bio Inc
27/03/202412:00GlobeNewswire Inc.Palisade Bio Reports Year End 2023 Financial Results and Provides Corporate UpdateNASDAQ:PALIPalisade Bio Inc
06/03/202421:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PALIPalisade Bio Inc
15/02/202413:35GlobeNewswire Inc.Palisade Bio to Present at Digestive Disease Week (DDW) 2024NASDAQ:PALIPalisade Bio Inc
14/02/202419:54Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PALIPalisade Bio Inc
14/02/202401:10Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PALIPalisade Bio Inc
13/02/202421:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PALIPalisade Bio Inc
13/02/202420:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PALIPalisade Bio Inc
13/02/202420:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PALIPalisade Bio Inc
13/02/202420:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PALIPalisade Bio Inc
 Showing the most relevant articles for your search:NASDAQ:PALI

Your Recent History

LSE
POLX
Polarean Imaging
LSE
GKP
Gulf Keystone Petroleum
LSE
PHNX
Phoenix
LSE
ZED
Zenova
LSE
RGL
Regional Reit
LSE
OBI
Ondine Biomedical
LSE
PHE
Powerhouse Energy
LSE
RKH
Rockhopper Exploration
LSE
W7L
Warpaint London
LSE
LLOY
Lloyds Banking
LSE
BOO
Boohoo
LSE
SSE
Sse
LSE
VEL
Velocity Composites
LSE
TERN
Tern
LSE
LGEN
Legal & General
LSE
NFDS
Northern Foods
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved